These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 551646)

  • 21. [Biological fate of 3H-labeled penfluridol. (3) Correlation between concentration of 3H-penfluridol in the brain and its anti-methamphetamine activity].
    Nakamura S; Ishida R; Sugihara J
    Radioisotopes; 1976 Oct; 25(10):637-40. PubMed ID: 1037406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new centrally acting DA-receptor agonist with selectivity for autoreceptors.
    Hjorth S; Carlsson A; Lindberg P
    Psychopharmacol Bull; 1980 Jul; 16(3):85-90. PubMed ID: 7403415
    [No Abstract]   [Full Text] [Related]  

  • 23. Behavioral effects of apomorphine during development of rats.
    Brus R; Herman ZS; Jamrozik Z
    Acta Physiol Pol; 1977; 28(3):243-6. PubMed ID: 561515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacology of penfluridol (R 16341) a new potent and orally long-acting neuroleptic drug.
    Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM; Verbruggen FJ; Van Nueten JM; Schaper WK
    Eur J Pharmacol; 1970 Jul; 11(2):139-54. PubMed ID: 5447800
    [No Abstract]   [Full Text] [Related]  

  • 25. Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist.
    Pawłowski L; Siwanowicz J; Bigajska K; Przegaliński E
    Pol J Pharmacol Pharm; 1985; 37(2):179-96. PubMed ID: 4048012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral effects and general pharmacology of 4-(5-chloro-benzofuranyl-2)-1-methylpiperidine HC1, an antidepressant inhibiting both monoamine oxidase A and 5-hydroxytryptamine uptake.
    Ortmann R; Radeke E; Buech O; Sigg K; Rogg H; Glatt A; Truog A; Jaekel J; Everitt BJ; Delini-Stula A
    Arzneimittelforschung; 1986 Dec; 36(12):1727-32. PubMed ID: 3566833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a new urinary metabolite of penfluridol in the rat, rabbit, dog, and man.
    Grindel JM; Migdalof BH; Hills JF
    Drug Metab Dispos; 1979; 7(6):448. PubMed ID: 43238
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
    Megens AA; Awouters FH; Meert TF; Schellekens KH; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):146-59. PubMed ID: 1370538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Genotypic differences in the metabolism of brain dopamine and in the dopamine-dependent forms of behavior in mice].
    Skrinskaia IuA; Nikulina EM
    Genetika; 1988 Jul; 24(7):1321-4. PubMed ID: 3181756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the action of (+/-)sulpiride on dopamine receptors in the rat brain in vivo.
    Hasan F; Leonard BE
    Neuropharmacology; 1981 Dec; 20(12B):1327-30. PubMed ID: 7198724
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antagonism between L-DOPA and apomorphine in their effects on rat behavior].
    Allikmets LKh; Zharkovskiĭ Am; Vasar EE
    Biull Eksp Biol Med; 1977 Jul; 84(7):51-3. PubMed ID: 560890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The central nervous system pharmacology of an anti-emetic dihydroindolone derivative.
    Holmes SW; Gylys JA
    Arzneimittelforschung; 1973 Sep; 23(9):1314-8. PubMed ID: 4204318
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuroleptic drugs and their action on different neuronal pathways.
    Ungerstedt U; Herrera-Marschitz M; Forster C
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):34-7. PubMed ID: 2858478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced turnover in mesolimbic dopamine neurons in 4-week-old offspring of nursing mothers treated with penfluridol.
    Engel J; Lundborg P
    Brain Res; 1976 Jul; 110(2):407-12. PubMed ID: 938954
    [No Abstract]   [Full Text] [Related]  

  • 35. [Electroencephalographic picture in patients treated with penfluridol].
    Zapletálek M; Hanus H; Kindernayová H; Stránský P; Valach M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1978; 21(5):573-8. PubMed ID: 292136
    [No Abstract]   [Full Text] [Related]  

  • 36. Supersensitivity to apomorphine and stress two years after chronic methadone treatment.
    Carlson KR
    Neuropharmacology; 1977 Nov; 16(11):795-8. PubMed ID: 413066
    [No Abstract]   [Full Text] [Related]  

  • 37. Open field behavior and gross motor development in offspring of nursing rat mothers given penfluridol.
    Ahlenius S; Engel J; Hård E; Larsson K; Lundborg P; Sinnerstedt P
    Pharmacol Biochem Behav; 1977 Mar; 6(3):343-7. PubMed ID: 857256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma prolactin and testosterone during penfluridol treatment.
    Nathan RS; Asnis GM; Dyrenfurth I; Halpern FS; Halbreich U; Ostrow LC; Sachar EJ
    Lancet; 1980 Jul; 2(8185):94. PubMed ID: 6105283
    [No Abstract]   [Full Text] [Related]  

  • 39. Preliminary observations on the interaction of domperidone with peripheral dopamine receptors.
    Willems JL; Bogaert MG; Buylaert W
    Jpn J Pharmacol; 1981 Feb; 31(1):131-3. PubMed ID: 7253336
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of growth and of thymidine incorporation into DNA in Tetrahymena by chlorpromazine, pimozide and penfluridol.
    Keegan FP; Blum JJ
    J Protozool; 1983 May; 30(2):397-402. PubMed ID: 6415270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.